Cited by 271Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure

Suskin, N·2000·European Heart Journal

DOI 10.1053/euhj.1999.2043

Open this paper in CoChat — free account

Abstract

AIMS: In addition to diabetes mellitus, less severe abnormalities of glucose and insulin metabolism may be related to functional status in patients with heart failure. We examined the relationship of hyperglycaemia (> or =6.1 mmol. l(-1)) and hyperinsulinaemia (> or =11.2 mU. l(-1)) to functional status and cardiac function in patients with heart failure. METHODS AND RESULTS: Fasting plasma glucose and insulin levels were obtained in 663 heart failure patients. The average left ventricular ejection fraction was 0.28+/-0.07, 63% were in New York Heart Association Functional Class (NYHA-FC) I/II and 37% were in NYHA-FC III/IV. Twenty seven percent had diabetes mellitus, but an additional 8% had undiagnosed diabetes mellitus (glucose > or =7 mmol. l(-1)) and 9% had glucose levels between 6.1 and 7 mmol. l(-1), so that a total of 43% (287) of patients had elevated glucose levels (> or =6.1 mmol. l(-1)). In general, more diabetic patients had NYHA-FC III/IV symptoms, shorter 6 min walk distances, but similar left ventricular ejection fractions compared to non-diabetic patients. The non-diabetic patients in NYHA-FC III/IV had higher glucose and insulin levels than patients in NYHA-FC I/II (6.3+/-0.2 vs 5.6+/-0.1 mmol. l(-1), P<0.001 and 19.6+/-2.3 vs 10. 2+/-0.6 mU. l(-1), P<0.001). Non-diabetic patients with elevated glucose levels had shorter 6 min walk distances compared to those with normal glucose levels (368.2+/-8 m vs 389.+/-4 m, P=0.02), however, left ventricular ejection fraction was similar. CONCLUSION: Glucose abnormalities are extremely common in heart failure patients (43% of patients). Diabetes mellitus and hyperglycaemia or hyperlinsulinaemia in non-diabetic patients were related to worse symptomatic status but not worsening left ventricular ejection fraction compared to patients with normal glucose and insulin levels.

Integrity signals

Registry

Crossref · 10.1053/euhj.1999.2043

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Hypertension and associated metabolic abnormalities–the role of insulin resistance and the sympathoadrenal system.
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,386
Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.
Goldman, L., Hashimoto, B. E., Cook, E. F., & Loscalzo, A. (1981) · Circulation · doi:10.1161/01.cir.64.6.1227 · Cited by 974
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
Cowie, M., Struthers, A. D., Wood, D. A., Coats, A. J. S., Thompson, S. G., Poole-Wilson, P. A., & Sutton, G. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06031-5 · Cited by 869
Effect of encouragement on walking test performance.
Guyatt, G. H., Pugsley, S. O., Sullivan, M. J., Thompson, P. J., Berman, L., Jones, N. L., Fallen, E. L., & Taylor, D. W. (1984) · Thorax · doi:10.1136/thx.39.11.818 · Cited by 816
Regulation of fatty acid oxidation in the mammalian heart in health and disease
Lopaschuk, G. D., Belke, D. D., Gamble, J., Toshiyuki, I., & Schönekess, B. O. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00082-4 · Cited by 552

Show all 28 references

Sorted by citations

Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,458
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 838
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
MacDonald, M. R., Petrie, M. C., Varyani, F., Ostergren, J., Michelson, E. L., Young, J. B., Solomon, S. D., Granger, C. B., Swedberg, K., Yusuf, S., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn153 · Cited by 694
Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Glucagon-Like Peptide-1 Infusion Improves Left Ventricular Ejection Fraction and Functional Status in Patients With Chronic Heart Failure
Sokos, G. G., Nikolaidis, L. A., Mankad, S. V., Elahi, D., & Shannon, R. P. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.08.211 · Cited by 654
Pathophysiology of Heart Failure
Tanai, E., & Frantz, S. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140055 · Cited by 696
Insulin Resistance and Risk of Congestive Heart Failure
Ingelsson, E., Sundström, J., Ärnlöv, J., Zethelius, B., & Lind, L. (2005) · JAMA · doi:10.1001/jama.294.3.334 · Cited by 569
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Seferović, P. M., & Paulus, W. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv134 · Cited by 552
Metabolic Mechanisms in Heart Failure
Ashrafian, H., Frenneaux, M. P., & Opie, L. H. (2007) · Circulation · doi:10.1161/circulationaha.107.702795 · Cited by 522
Pathophysiology of heart failure
Schwinger, R. H. G. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-302 · Cited by 525
Insulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 356
Cardiac cachexia: A systematic overview
von Haehling, S., Lainščak, M., Springer, J., & Anker, S. D. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.009 · Cited by 356
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure
von Haehling, S., Doehner, W., & Anker, S. D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.018 · Cited by 300
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
Doehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I. F., von Haehling, S., Okonko, D. O., Leyva, F., Proudler, A. J., Coats, A. J. S., & Anker, S. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.093 · Cited by 294
Insulin resistance in pulmonary arterial hypertension
Zamanian, R. T., Hansmann, G., Snook, S., Lilienfeld, D. E., Rappaport, K., Reaven, G. M., Rabinovitch, M., & Doyle, R. L. (2008) · European Respiratory Journal · doi:10.1183/09031936.00000508 · Cited by 269
Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure
Gustafsson, I., Brendorp, B., Seibæk, M., Burchardt, H., Hildebrandt, P., Køber, L., & Torp-Pedersen, C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.024 · Cited by 258
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., & McMurray, J. J. V. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn156 · Cited by 227
Testosterone Therapy in Women With Chronic Heart Failure
Iellamo, F., Volterrani, M., Caminiti, G., Karam, R., Massaro, R., Fini, M., Collins, P. D., & Rosano, G. M. C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.090 · Cited by 212
Testosterone Supplementation in Heart Failure
Toma, M., McAlister, F. A., Coglianese, E. E., Vidi, V. D., Vasaiwala, S. C., Bakal, J. A., Armstrong, P. W., & Ezekowitz, J. A. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.965632 · Cited by 197
p53-Induced Adipose Tissue Inflammation Is Critically Involved in the Development of Insulin Resistance in Heart Failure
Shimizu, I., Yoshida, Y., Katsuno, T., Tateno, K., Okada, S., Moriya, J., Yokoyama, M., Nojima, A., Ito, T. K., Zechner, R., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.006 · Cited by 192
Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure
McMurray, J. J. V., Ponikowski, P., Bolli, G. B., Lukashevich, V., Kozlovski, P., Kothny, W., Lewsey, J. D., & Krum, H. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2017.08.004 · Cited by 165
Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
Halbirk, M., Nørrelund, H., Møller, N., Holst, J. J., Schmitz, O., Nielsen, R. R., Nielsen‐Kudsk, J. E., Nielsen, S. S., Nielsen, T. T., Eiskjær, H., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00930.2009 · Cited by 165
miR-26a Limits Muscle Wasting and Cardiac Fibrosis through Exosome-Mediated microRNA Transfer in Chronic Kidney Disease
Wang, B., Zhang, A., Wang, H., Klein, J. D., Tan, L., Wang, Z., Du, J., Naqvi, N., Liu, B., & Wang, X. H. (2019) · Theranostics · doi:10.7150/thno.29579 · Cited by 161
Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry
Echouffo-Tcheugui, J. B., Xu, H., DeVore, A. D., Schulte, P. J., Butler, J., Yancy, C. W., Bhatt, D. L., Hernandez, A. F., Heidenreich, P. A., & Fonarow, G. C. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.07.025 · Cited by 160
Effects of β-blockers on glucose and lipid metabolism
Fonseca, V. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903533681 · Cited by 162
Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database
MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J. R., & McAlister, F. A. (2010) · Diabetes Care · doi:10.2337/dc09-2227 · Cited by 149
Comparative study on the predictive value of TG/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study
Zhou, Z., Liu, Q., Zheng, M., Zuo, Z., Zhang, G., Shi, R., & Wu, T. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02308-w · Cited by 143
The triglyceride–glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis
Li, C., Zhang, Z., Luo, X.-Q., Xiao, Y., Tu, T., Liu, C., Liu, Q., Wang, C., Dai, Y., Zhang, Z., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02591-1 · Cited by 136
Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
Cittadini, A., Napoli, R., Monti, M. G., Rea, D., Longobardi, S., Netti, P. A., Walser, M., Samà, M., Aimaretti, G., Isgaard, J., et al. (2012) · Diabetes · doi:10.2337/db11-1132 · Cited by 130
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
Palazzuoli, A., & Iacoviello, M. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10238-6 · Cited by 128
Adequate Energy-Protein Intake is Not Enough to Improve Nutritional and Metabolic Status in Muscle-Depleted Patients with Chronic Heart Failure
Aquilani, R., Opasich, C., Gualco, A., Verri, M., Testa, A., Pasini, E., Viglio, S., Iadarola, P., Pastoris, O., Dossena, M., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.09.002 · Cited by 118
Frequent Non-Cardiac Comorbidities in Patients with Chronic Heart Failure
Dahlström, U. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.008 · Cited by 114
Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population‐based controls
Bartnik, M., Malmberg, K., Hamsten, A., Efendić, S., Norhammar, A., Silveira, A. M. V., Tenerz, Å., Öhrvik, J., & Rydén, L. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01371.x · Cited by 111
Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure
Barsheshet, A., Garty, M., Grossman, E., Sandach, A., Lewis, B. S., Gottlieb, S., Shotan, A., Behar, S., Caspi, A., Schwartz, R., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1613 · Cited by 110
Mechanisms of Cachexia in Chronic Disease States
Yoshida, T., & Delafontaine, P. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000511 · Cited by 117
The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma
Rothhammer-Hampl, T., Hahne, J. C., Florin, A., Poser, I., Soncin, F., Wernert, N., & Bosserhoff, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3337-8 · Cited by 110
Novel Metabolic Risk Factors for Heart Failure
Ingelsson, E., Ärnlöv, J., Sundström, J., Zethelius, B., Vessby, B. O., & Lind, L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.059 · Cited by 108
Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure
AlZadjali, M. A., Godfrey, V., Khan, F., Choy, A. M., Doney, A. S. F., Wong, A., Petrie, J. R., Struthers, A. D., & Lang, C. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.081 · Cited by 106
The Effect of Metformin on Insulin Resistance and Exercise Parameters in Patients with Heart Failure
Wong, A., Symon, R., AlZadjali, M. A., Ang, D. S. C., Ogston, S. A., Choy, A. M., Petrie, J. R., Struthers, A. D., & Lang, C. C. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs106 · Cited by 104
Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 100
Functional class in patients with heart failure is associated with the development of diabetes
Tenenbaum, A., Motro, M., Fisman, E. Z., Leor, J., Freimark, D., Boyko, V., Mandelzweig, L., Adler, Y., Sherer, Y., & Behar, S. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01530-9 · Cited by 99
Heart Failure as a Multiple Hormonal Deficiency Syndrome
Saccà, L. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.821892 · Cited by 94
Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
Evans, J. M. M., Doney, A. S. F., AlZadjali, M. A., Ogston, S. A., Petrie, J. R., Morris, A. D., Struthers, A. D., Wong, A., & Lang, C. C. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.031 · Cited by 95
The Association of Heart Failure With Insulin Resistance and the Development of Type 2 Diabetes
Kostis, J. B., & SANDERS, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.038 · Cited by 93
The PPARγ-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction
Lygate, C. A. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00289-x · Cited by 89
Novel Diabetes Drugs and the Cardiovascular Specialist
Sattar, N. A., Petrie, M. C., Zinman, B., & Januzzi, J. L. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.014 · Cited by 88
High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2
Tang, M., Zhang, W. J., Lin, H., Jiang, H., Dai, H., & Zhang, Y. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9401-6 · Cited by 79
Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system
Jones, T. H., & Kelly, D. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_6_18 · Cited by 76
Combined Thiazolidinedione-Insulin Therapy
Scheen, A. J. (2004) · Drug Safety · doi:10.2165/00002018-200427120-00002 · Cited by 73
Growth Hormone Replacement Delays the Progression of Chronic Heart Failure Combined With Growth Hormone Deficiency
Cittadini, A., Marra, A. M., Arcopinto, M., Bobbio, E., Salzano, A., Sirico, D., Napoli, R., Colao, A., Longobardi, S., Baliga, R. R., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.04.003 · Cited by 71
Cardiac Insulin Resistance in Heart Failure: The Role of Mitochondrial Dynamics
Saotome, M., Ikoma, T., Hasan, P., & Maekawa, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143552 · Cited by 71
Comprehensive Care Models for Cardiometabolic Disease
Reiter–Brennan, C., Dzaye, O. D. A., Davis, D. M., Blaha, M., & Eckel, R. H. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01450-1 · Cited by 76
Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes
Sud, M. K., Wang, X., Austin, P. C., Lipscombe, L. L., Newton, G. E., Tu, J. V., Vasan, R. S., & Lee, D. S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu462 · Cited by 72
Insulin Treatment and Clinical Outcomes in Patients with Diabetes and Heart Failure with Preserved Ejection Fraction
Shen, L., Rørth, R., Cosmi, D., Kristensen, S. L., Petrie, M. C., Cosmi, F., Latini, R., Køber, L., Anand, I. S., Carson, P. E., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1535 · Cited by 69
Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure
Berry, C., Brett, M., Stevenson, K. S., McMurray, J. J. V., & Norrie, J. D. (2007) · Heart · doi:10.1136/hrt.2006.110999 · Cited by 69
Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia
Trobec, K. Č., von Haehling, S., Anker, S. D., & Lainščak, M. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0043-5 · Cited by 69
Co-morbidities in heart failure
van Deursen, V. M., Damman, K., van der Meer, P., Wijkstra, P. J., Luijckx, G. J., van Beek, A. P., van Veldhuisen, D. J., & Voors, A. A. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9370-7 · Cited by 67
STAT1/3 and ERK1/2 Synergistically Regulate Cardiac Fibrosis Induced by High Glucose
Dai, B., Cui, M., Zhu, M. J., Su, W., Qiu, M.-C., & Zhang, H. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354499 · Cited by 66
Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?
Miller, A. M., Purves, D. G., McConnachie, A., Asquith, D. L., Batty, G. D., Burns, H., Cavanagh, J., Ford, I., McLean, J. S., Packard, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047830 · Cited by 66
Insulin Signalling and Resistance in Patients with Chronic Heart Failure
Kemppainen, J., Tsuchida, H., Stolen, K. Q., Karlsson, H., Björnholm, M., Heinonen, O. J., Nuutila, P., Krook, A., Knuuti, J. M., & Zierath, J. R. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042648 · Cited by 65
Discordant Short- and Long-Term Outcomes Associated With Diabetes in Patients With Heart Failure: Importance of Age and Sex: A Population Study of 5.1 Million People in Scotland
MacDonald, M. R., Jhund, P. S., Petrie, M. C., Lewsey, J. D., Hawkins, N. M., Bhagra, S., Munoz, N., Varyani, F., Redpath, A., Chalmers, J., et al. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.794008 · Cited by 64
Heart Failure and Loss of Metabolic Control
Wang, Z. V., Li, D. ‘., & Hill, J. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000054 · Cited by 63
Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study
Roux, J. A. F., Colet, J. C., Pedro‐Botet, J., Benaiges, D., de Dou, J. P., Chillarón, J. J., Goday, A., Bruguera, J., & Cano-Pérez, J. F. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-39 · Cited by 61
Beneficial Effects of Testosterone Therapy on Functional Capacity, Cardiovascular Parameters, and Quality of Life in Patients with Congestive Heart Failure
Mirdamadi, A., Garakyaraghi, M., Pourmoghaddas, A., Bahmani, A., Mahmoudi, H., & Gharipour, M. (2014) · BioMed Research International · doi:10.1155/2014/392432 · Cited by 63
Prevalence and Prognostic Implications of Pre-Diabetic State in Patients With Heart Failure
Matsue, Y., Suzuki, M., Nakamura, R. A., Abe, M., Ono, M., Yoshida, S., Seya, M., Iwatsuka, R., Mizukami, A., Setoguchi, M., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0754 · Cited by 61
Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice
Takahashi, A., Asakura, M., Ito, S., Min, K.-D., Shindo, K., Yan, Y., Liao, Y., Yamazaki, S., Sanada, S., Asano, Y., et al. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00454.2012 · Cited by 61
ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance
Kalfon, R., Koren, L., Aviram, S., Schwartz, O., Hai, T., & Aronheim, A. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw228 · Cited by 59
Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality
Parissis, J. T., Rafouli-Stergiou, P., Mebazaa, A., Ikonomidis, I., Bistola, V., Nikolaou, M., Meas, T., Delgado, J., Vilas-Boas, F., Paraskevaidis, I., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.098 · Cited by 58
A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 67
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry
Cittadini, A., Salzano, A., Iacoviello, M., Triggiani, V., Rengo, G., Cacciatore, F., Maiello, C., Limongelli, G., Masarone, D., Perticone, F., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab020 · Cited by 55
Fasting Glucose in Acute Myocardial Infarction
Aronson, D., Hammerman, H., Kapeliovich, M. R., Suleiman, A., Agmon, Y., Beyar, R., Markiewicz, W., & Suleiman, M. A. (2007) · Diabetes Care · doi:10.2337/dc06-1735 · Cited by 52
Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)
Martin, D. T., McNitt, S., Nesto, R. W., Rutter, M. K., & Moss, A. J. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959510 · Cited by 51
Long-Term Outcome in Diabetic Heart Failure Patients Treated with Cardiac Resynchronization Therapy
Fantoni, C., Regoli, F. D., Ghanem, A., Raffa, S., Klersy, C., Sorgente, A., Faletra, F. F., Baravelli, M., Inglese, L., Salerno‐Uriarte, J. A., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.01.006 · Cited by 49
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry
On behalf of TOSCA Investigators, Bossone, E., Arcopinto, M., Iacoviello, M., Triggiani, V., Cacciatore, F., Maiello, C., Limongelli, G., Masarone, D., Perticone, F., et al. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1844-8 · Cited by 48
Hyperglycemia and angiotensin II cooperate to enhance collagen I deposition by cardiac fibroblasts through a ROS-STAT3-dependent mechanism
Fiaschi, T., Magherini, F., Gamberi, T., Lucchese, G., Faggian, G. G., Modesti, A., & Modesti, P. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.07.009 · Cited by 47
Macrovascular complications of metabolic syndrome: an early intervention is imperative
Tenenbaum, A., Motro, M., Schwammenthal, E., & Fisman, E. Z. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.07.033 · Cited by 47
Effects of methylglyoxal on human cardiac fibroblast: roles of transient receptor potential ankyrin 1 (TRPA1) channels
Oguri, G., Nakajima, T., Yamamoto, Y., Takano, N., Tanaka, T., Kikuchi, H., Morita, T., Nakamura, F., Yamasoba, T., & Komuro, I. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01021.2013 · Cited by 47
Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study
Roberts, T. J., Burns, A., MacIsaac, R. J., MacIsaac, A. I., Prior, D., & Gerche, A. L. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0688-x · Cited by 46
Effects of Combined Candesartan and ACE Inhibitors on BNP, Markers of Inflammation and Oxidative Stress, and Glucose Regulation in Patients With Symptomatic Heart Failure
White, M., Lepage, S., Lavoie, J., de Denus, S., Leblanc, M.-H., Gossard, D., Whittom, L., Racine, N., Ducharme, A., Dabouz, F., et al. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.10.013 · Cited by 47
Impaired Glucose Metabolism in Patients with Heart Failure
Tenenbaum, A., & Fisman, E. Z. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404050-00001 · Cited by 46
Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice
Liao, Y., Takashima, S., ZHAO, H., ASANO, Y., Shintani, Y., Minamino, T., KIM, J., Fujita, M., HORI, M., & Kitakaze, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.021 · Cited by 45
Testosterone and heart failure
Volterrani, M., Rosano, G. M. C., & Iellamo, F. (2012) · Endocrine · doi:10.1007/s12020-012-9725-9 · Cited by 44
Oral Glucose Tolerance Testing in an Outpatient Heart Failure Clinic Reveals a High Proportion of Undiagnosed Diabetic Patients with an Adverse Prognosis
Egstrup, M., Schou, M., Gustafsson, I., Kistorp, C., Hildebrandt, P. R., & Tuxen, C. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq216 · Cited by 44
The regulation of muscle protein turnover in diabetes
Workeneh, B., & Bajaj, M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.028 · Cited by 41
Hormone replacement therapy in heart failure
Arcopinto, M., Salzano, A., Isgaard, J., & Cittadini, A. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000166 · Cited by 37
Impaired Glucose Tolerance and Insulin Resistance in Heart Failure: Underrecognized and Undertreated?
Mamas, M. A., Deaton, C., Rutter, M. K., Yuille, M., Williams, S. G., Ray, S. G., New, J. P., Gibson, M., & Neyses, L. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.027 · Cited by 42
Association of hyponatremia and hyperglycemia with outcome in dogs with congestive heart failure
Brady, C. A., Hughes, D., & Drobatz, K. J. (2004) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1534-6935.2004.00118.x · Cited by 42
Hypo- and Hyperglycemia Predict Outcome in Patients With Left Ventricular Dysfunction After Acute Myocardial Infarction: Data From EPHESUS
Ukena, C., Dobre, D., Mahfoud, F., Kindermann, I., Lamiral, Z., Tala, S., Rossignol, P., Turgonyi, E., Pitt, B., Böhm, M., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.03.002 · Cited by 41
Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease — do we need to screen our patients?
Roberts, A. W., Clark, A. L., & Witte, K. K. (2009) · Diabetes and Vascular Disease Research · doi:10.1177/1479164109338774 · Cited by 43
Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations
Giles, T. D., & Sander, G. E. (2004) · Cardiology Clinics · doi:10.1016/j.ccl.2004.07.002 · Cited by 41
Influence of diabetes mellitus and hyperglycemia on prognosis in patients ≥70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS])
de Boer, R. A., Doehner, W., van der Horst, I. C. C., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J., Flather, M. D., & van Veldhuisen, D. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.02.018 · Cited by 39
Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship
Wilkinson, M. J., Zadourian, A., & Taub, P. R. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.024 · Cited by 40
Heart Failure as a Risk Factor for Diabetes Mellitus
Guglin, M. E., Lynch, K. F., & Krischer, J. P. (2014) · Cardiology · doi:10.1159/000363282 · Cited by 38
Diabetic cardiomyopathy
Karnik, A. A., Fields, A. V., & Shannon, R. P. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0086-3 · Cited by 37
Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts
Zhou, H., Zhang, K.-X., Li, Y., Guo, B., Wang, M., & Wang, M. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05523.x · Cited by 36
Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction
Pavlovic, A. S., Polovina, M. M., Ristić, A. D., Seferović, J. P., Veljić, I., Simeunović, D. S., Milinković, I., Krljanać, G., Ašanin, M., Ostric, I., et al. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318807767 · Cited by 36
Insulin Resistance Is Associated With Heart Failure With Recovered Ejection Fraction in Patients Without Diabetes
Yang, C. D., Pan, W. Q., Feng, S., Quan, J. W., Chen, J. W., Shu, X. Y., Aihemaiti, M., Ding, F. H., Shen, W. F., Lu, L., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026184 · Cited by 37
Possible Heart Failure Exacerbation Associated with Rosiglitazone: Case Report and Literature Review
Page, R. L., II, Gozansky, W. S., & Ruscin, J. M. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.7.945.32721 · Cited by 34
Prevalence and characteristics of diabetic patients in a chronic heart failure population
Kistorp, C., Galatius, S., Gustafsson, F., Faber, J., Corell, P., & Hildebrandt, P. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.024 · Cited by 33
Diabetes mellitus and the heart
Mercer, B. N., Morais, S. R. D. L. O. K., Cubbon, R. M., & Kearney, M. T. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02924.x · Cited by 33

Authors: Suskin, N.
Affiliations: London Health Sciences Centre (CA)
Corresponding author: Suskin, N
ORCID: Suskin, N
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2000-08-15
Volume: 21
Issue: 16
Pages: 1368-1375
ISSN: 0195-668X (ISSN-L)
DOI: 10.1053/euhj.1999.2043
OpenAlex: W2158721215
Cited by: 271
References: 28
Citations by year: 2026: 2 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 6 · 2019: 18 · 2018: 7 · 2017: 7 · 2016: 11 · 2015: 9 · 2014: 11 · 2013: 11 · 2012: 18
FWCI: 3.46
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: congestive heart failure, hyperglycemia, hyperinsulinemia, glucose metabolism, insulin metabolism, functional capacity, NYHA functional class, 6-minute walk distance, left ventricular ejection fraction, diabetes mellitus, undiagnosed diabetes, cardiac function
MeSH terms: Blood Glucose, Diabetes Mellitus, Exercise Test, Female, Heart Failure, Humans, Hyperglycemia, Hyperinsulinism, Insulin, Insulin Resistance, Male, Middle Aged, Myocardial Contraction, Pilot Projects, Prognosis, Risk Factors, Stroke Volume, Cohort Studies, Biomarkers, Incidence, Ventricular Function, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks